Physician profile
Leonard Lapkin
NPI 1437131455
$5,910.90
in general payments reported to CMS, 2019-2025
8 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456 · 2020: $142 · 2021: $280 · 2022: $2,773 · 2023: $1,726 · 2024: $197 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,374 · Food and Beverage: $886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,373.90 |
| Food and Beverage | $885.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $4,228.00 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Edwards Lifesciences Corporation | $1,025.78 | 2019-2025 | Inspiris Resilia Aortic Valve |
| Abbott Laboratories | $311.41 | 2019-2025 | Mitraclip |
| Medtronic, INC. | $188.21 | 2022-2024 | Corevalve Evolut R |
| Abiomed | $76.36 | 2022 | |
| Impulse Dynamics (USA) INC. | $55.69 | 2023 | Optimizer |
| Medtronic Vascular, INC. | $13.50 | 2019 | |
| Olympus America INC. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Lapkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.